1. Christopher Jon Olesch Jr. Christopher Jon Olesch Jr. United States says:

    Why waste our time & resources when most of these problems have already been solved by other countries.
    European regulatory authorities aim to minimise the impact of medicine shortages on patients by:

        working with pharmaceutical companies to resolve manufacturing and distribution issues;
        sharing information with international partners about alternative sources of supply;
        seeking input from patients and healthcare professionals on the impact of medicine shortages, to support decision-making;
        taking measures to allow alternative medicines or suppliers to be used.

    The Agency maintains a catalogue of shortages that it has assessed.
    www.ema.europa.eu/.../general_content_000588.jsp&mid=WC0b01ac05807477a5

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.